Actively Recruiting
TSA vs RSA in Glenohumeral Osteoarthritis
Led by Ottawa Hospital Research Institute · Updated on 2025-03-25
108
Participants Needed
4
Research Sites
668 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study will compare total shoulder arthroplasty (TSA) reverse shoulder arthroplasty (RSA) procedures, in the context of a prospective, randomized-controlled trial to determine the optimal treatment in patients 65 years of age and older, and equal to or less than 15 degrees of glenoid retroversion, who have glenohumeral osteoarthritis.
CONDITIONS
Official Title
TSA vs RSA in Glenohumeral Osteoarthritis
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients who have persistent pain and disability from idiopathic shoulder osteoarthritis despite at least 6 months of standard non-surgical treatment including medications, physiotherapy, and activity changes
- Imaging and surgical findings showing advanced cartilage loss in the shoulder joint
- Glenoid deficiency with 15 degrees or less of retroversion
- Age 65 years or older
You will not qualify if you...
- Active joint or systemic infection
- Rotator cuff arthropathy
- Significant muscle paralysis
- Charcot's arthropathy
- Major medical illness with life expectancy less than 1 year or very high surgical risk
- Unable to understand the consent process
- Pregnancy
- Psychiatric illness preventing informed consent
- Unwilling to be followed for the full study duration
- Retroversion that cannot be corrected surgically to within 10 degrees of neutral
- Previous shoulder surgery on the affected side
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 4 locations
1
University of Alberta
Edmonton, Alberta, Canada, T6G2G3
Not Yet Recruiting
2
Pan Am Clinic Foundation
Winnipeg, Manitoba, Canada, R3M3E4
Not Yet Recruiting
3
Kingston General Hospital (Site-Watkins 3)
Kingston, Ontario, Canada, K7L 2V7
Actively Recruiting
4
The Ottawa Hospital
Ottawa, Ontario, Canada, K1H8L6
Actively Recruiting
Research Team
P
Peter Lapner Lapner, MD
CONTACT
K
Katie McIlquham
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here